Original Literature | Model OverView |
---|---|
Publication
Title
Shared principles in NF-kappaB signaling.
Affiliation
Department of Immunobiology, Yale University School of Medicine, New Haven, CT06510, USA.
Abstract
The transcription factor NF-kappaB has served as a standard for inducibletranscription factors for more than 20 years. The numerous stimuli that activateNF-kappaB, and the large number of genes regulated by NF-kappaB, ensure thatthis transcription factor is still the subject of intense research. Here, weattempt to synthesize some of the basic principles that have emerged fromstudies of NF-kappaB, and we aim to generate a more unified view of NF-kappaBregulation.
PMID
18267068
|
Entity
Process
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68
10
infinite
0
TRANSPATH | MO000000058 |
--
RIP1
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m43
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
NIK
--
MO000000203
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m174
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000203 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IkappaB-alpha
--
MO000000233
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m199
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000233 |
--
IkappaB-beta
--
MO000000234
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m200
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000234 |
--
Bcl-3
--
MO000000238
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m204
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000238 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
20S proteasome
--
MO000000291
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m232
10
infinite
0
TRANSPATH | MO000000291 |
--
TAK1
--
MO000016574
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1573
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
IKK-gamma
--
MO000016599
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1593
10
infinite
0
InterPro | IPR007087 |
TRANSPATH | MO000016599 |
--
(p50)2
--
MO000016636
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1621
10
infinite
0
TRANSPATH | MO000016636 |
--
p52:p52
--
MO000016637
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1622
10
infinite
0
TRANSPATH | MO000016637 |
--
IKK-alpha:IKK-beta:(IKK-gamma)n
--
MO000016661
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1637
10
infinite
0
TRANSPATH | MO000016661 |
--
TRAF3
--
MO000016963
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1872
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000016963 |
--
CREB
--
MO000017189
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2057
10
infinite
0
InterPro | IPR003102 |
TRANSPATH | MO000017189 |
--
GSK3beta
--
MO000017332
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2177
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017332 |
--
CBP
--
MO000017462
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2282
10
infinite
0
InterPro | IPR000433 |
TRANSPATH | MO000017462 |
--
SCF-betaTrCP
--
MO000018837
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3459
10
infinite
0
TRANSPATH | MO000018837 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
HDAC3
--
MO000023574
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m7349
10
infinite
0
InterPro | IPR003084 |
TRANSPATH | MO000023574 |
--
IKK-alpha:IKK-beta
--
MO000033291
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m11981
10
infinite
0
TRANSPATH | MO000033291 |
--
IKK-alpha{p}
--
MO000038331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16546
10
infinite
0
TRANSPATH | MO000038331 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IkappaB-zeta
--
e100
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
IkappaB-zeta
--
e101
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m103
0
infinite
0
--
IkappaB-zeta
--
e102
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m104
0
infinite
0
--
(p50)2:IkappaB-zeta
--
e103
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m105
0
infinite
0
--
csml-variable:Double
m106
0
infinite
0
--
IL-6:(p50)2:IkappaB-zeta
--
e105
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m107
0
infinite
0
--
Ikappa-Balpha:p50:p65:PKAc
--
e106
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m109
0
infinite
0
--
Ikappa-Balpha{p}:p50:p65:PKAc
--
e107
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m110
0
infinite
0
--
p50:p65{p}
--
e108
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m111
0
infinite
0
--
MSK2
--
e109
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m112
0
infinite
0
--
Ikappa-Balpha:p50:p65
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
p50:p65{p}:CBP:p300
--
e110
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m113
0
infinite
0
--
p50:p65{p}{ace}:CBP:p300
--
e111
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m114
0
infinite
0
--
p50:p65
--
e112
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m115
0
infinite
0
--
p50:p65:SMRT:HDAC3
--
e113
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m116
0
infinite
0
--
IKK-alpha
--
e114
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m117
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
p50:p65:SMRT{p}:HDAC3
--
e115
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m118
0
infinite
0
--
csml-variable:Double
m119
0
infinite
0
--
Histone H3{p}:DNA
--
e117
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m120
0
infinite
0
--
CBP{p}
--
e118
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m121
0
infinite
0
--
p50:p65:SMRT{p}
--
e119
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m122
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
p53:CBP
--
e120
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m123
0
infinite
0
--
CREB{p}
--
e121
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m124
0
infinite
0
--
CREB:CBP
--
e122
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m125
0
infinite
0
--
CREB:CBP{p}
--
e123
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m126
0
infinite
0
--
p50:p65:RPS3
--
e124
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m127
0
infinite
0
--
COMMD1
--
e125
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m128
0
infinite
0
--
ECS-SOCS1
--
e126
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m129
0
infinite
0
--
p50:p65:COMMD1:ECS-SOCS1
--
e127
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m130
0
infinite
0
--
protein remnants
--
e128
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m131
10
infinite
0
TRANSPATH | MO000019479 |
--
csml-variable:Double
m13
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:TRAF2IKK complex:RIP1{ub}
--
e130
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m133
0
infinite
0
--
RIP1{ub}:Nemo{ub}:TRAF2:TRAdd:TNFR1:TNF
--
e131
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m134
0
infinite
0
--
IKK-alpha:IKK-beta:(IKK-gamma)n {p}
--
e132
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m135
10
infinite
0
TRANSPATH | MO000016661 |
--
IKK-alpha:IKK-beta:(IKK-gamma)n {p}
--
e133
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m136
10
infinite
0
TRANSPATH | MO000016661 |
--
IKK-alpha{p}:IKK-beta{p}
--
e134
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m137
0
infinite
0
--
PP2a:IKK-alpha{p}:IKK-beta{p}
--
e135
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m138
0
infinite
0
--
PP2a:IKK-alpha:IKK-beta
--
e136
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m139
0
infinite
0
--
TRAFs
--
e137
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m140
0
infinite
0
--
NOD ligand complex:RIP2{ub}
--
e138
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m141
0
infinite
0
--
RelA-p65:p100
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
Ikappa-Balpha{p}{ub}:p50:p65:PKAc
--
e15
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m15
0
infinite
0
--
PKAc:p65:p50
--
e17
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m17
0
infinite
0
--
UbcH5
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
PKAc:p65{p}:p50
--
e19
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
p50:p65{p}
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
genes
--
e21
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
IL-1:IL-1R
--
e23
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m23
0
infinite
0
--
IL-1R
--
e24
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m24
0
infinite
0
--
IL-1:IL-1R:MYD88
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
dsRNA:DDX58
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
dsRNA:DDX58:MAVS
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IKK-alpha:IKK-beta:(IKK-gamma)2:Cdc37:Hsp-90
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
TNF-alpha:TNFR1
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TNF-alpha:TNFR1:TRADD
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:TRAF2
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:TRAF5
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
IL-1:IL-1R:MYD88:Traf6
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
LPS:TLR4
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
LPS:TLR4:MYD88
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
LPS:TLR4:MYD88:TRAF6
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
ligand:receptor complex
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
ligand:receptor complex:TRAF3
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
IKK-alpha
--
e39
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m39
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
ligand:receptor complex:TRAF3:NIK
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
NIK{ub}
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
ligand:receptor complex:TRAF3{ub}:NIK
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:RIP1:TRAF2
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:RIP1:IKK
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:RIP1:IKK{active}
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m46
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:TRAF2:IKK
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
TNF-alpha:TNFR1:TRADD:RIP1{ub}:TRAF2
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
LPS:TLR4:TRIF
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
LPS:TLR4:TRIF:RIP1
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
p50:p65
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Ikappa-Balpha:p50:p65
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
dsRNA:TLR3
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
dsRNA:TLR3:TRIF
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
(IKK-alpha)2
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
NF-kappaB{active}
--
e67
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
TRANSPATH | MO000000058 |
--
ligand:TCR complex
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
ligand:BCR complex
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
CBM complex
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
(IKK-gamma)n
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
NOD:ligand complex
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
NOD:ligand:RIP2
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
NOD:ligand:RIP2:IKK
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m76
0
infinite
0
--
NOD:ligand:RIP2:IKK
--
e75
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
(IKK-beta)2
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
IKK-beta:IKK-gamma
--
e77
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m79
0
infinite
0
--
IKK-alpha:IKK-gamma
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
IKK-alpha:IKK-beta:(IKK-gamma)n
--
e79
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m81
10
infinite
0
TRANSPATH | MO000016661 |
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
csml-variable:Double
m82
0
infinite
0
--
IKK-alpha:IKK-beta:(IKK-gamma)2:ELKS
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m83
0
infinite
0
--
IKK-beta{p}
--
e82
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m84
0
infinite
0
--
CBM oligomer
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
IkappaB-beta{p}
--
e84
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
IkappaB-alpha
--
e85
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m87
0
infinite
0
--
IkappaB-epsilon
--
e86
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m88
0
infinite
0
--
DNA:p50:p65:IkappaB-beta
--
e88
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m90
0
infinite
0
--
p105:NF-kappaB
--
e89
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
(RelB)2
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
p100:(RelB)2
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m93
0
infinite
0
--
p100{p}:SCF-betaTRCP
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m94
0
infinite
0
--
p100{p}{ub}:SCF-betaTRCP
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m95
0
infinite
0
--
p52:(RelB)2
--
e94
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m96
0
infinite
0
--
p52:p52:BCL3
--
e95
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m97
0
infinite
0
--
BCL3:p50:p65
--
e96
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m98
0
infinite
0
--
(p50)2:BCL3
--
e97
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m99
0
infinite
0
--
Cyclin D1
--
e98
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m100
0
infinite
0
--
Hdm2
--
e99
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m101
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c3 : 1
stoichiometry:c269 : 1
stoichiometry:c270 : 1
m5*m199*m108*0.1
nodelay
--
0
PMID: 18267068 I¦ÊB¦Á is rapidly degraded during activation of canonical NF-¦ÊB signaling pathways leading to the release of multiple NF-¦ÊB dimers, although the p65:p50 heterodimer is likely the primary target of I¦ÊB¦Á. PMID: 18267068, 9660950 PKA exists in a complex with cytosolic NF-¦ÊB:I¦ÊB complexes and following degradation of I¦ÊB¦Á phosphorylates p65 at Ser276, promoting the interaction of p65 with the transcriptional coactivators CBP (CREB-binding protein) and p300
p10
p10
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c91 : 1
stoichiometry:c24 : 1
m16*m16546*0.1
nodelay
--
0
PMID: 18267068 The noncanonical pathway, conversely, depends only on the IKK¦Á subunit, which functions by phosphorylating p100 and causing its inducible processing to p52.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c282 : 1
stoichiometry:c284 : 1
stoichiometry:c283 : 1
m17*m39*0.1
nodelay
--
0
PMID: 18267068, 15122352, 17072324 IKK¦Á and IKK¦Â have been implicated in the direct phosphorylation of p65 at Ser536
p101
p101
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c285 : 1
stoichiometry:c287 : 1
stoichiometry:c286 : 1
m17*m2228*0.1
nodelay
--
0
PMID: 18267068, 9405476, 10938077 Ser529 of p65 may also be inducibly phosphorylated by CK2 following IL-1 or TNF-¦Á stimulation, although it is unclear whether Ser529 phosphorylation affects transcription
p102
p102
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c288 : 1
stoichiometry:c290 : 1
stoichiometry:c289 : 1
m17*m1631*0.1
nodelay
--
0
PMID: 18267068, 12881425 PKC¦Æ can phosphorylate p65 at Ser311, and CBP fails to associate with p65 following stimulation of PKC¦Æ-deficient cells
p103
p103
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c291 : 1
stoichiometry:c293 : 1
stoichiometry:c309 : 1
stoichiometry:c294 : 1
m111*m4512*m121*0.1
nodelay
--
0
PMID: 18267068, 9660950 PKA exists in a complex with cytosolic NF-¦ÊB:I¦ÊB complexes and following degradation of I¦ÊB¦Á phosphorylates p65 at Ser276, promoting the interaction of p65 with the transcriptional coactivators CBP (CREB-binding protein) and p300. PMID: 18267068, 17434128 It was recently reported that IKK¦Á phosphorylates CBP in a stimulus-dependent manner, inducing upregulation of CBP activity, increased binding to p65, and decreased binding to p53
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c295 : 1
stoichiometry:c296 : 1
m113*0.1
nodelay
--
0
PMID: 18267068, 15122352 Acetylation of p65, probably by CBP/p300 and associated HATs, occurs in the nucleus and is associated with increased transcription PMID: 18267068 p65 phosphorylation is necessary to recruit CBP/p300 allowing acetylation at Lys310
p105
p105
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c297 : 1
stoichiometry:c298 : 1
stoichiometry:c300 : 1
stoichiometry:c299 : 1
m115*m10730*m7349*0.1
nodelay
--
0
PMID: 18267068, 16382138 One possibility is that Ser536 phosphorylation alters the interaction of p65 with the SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor complex such that the level of HDAC3 is decreased and CBP/p300 is increased.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c301 : 1
stoichiometry:c303 : 1
stoichiometry:c302 : 1
m116*m117*0.1
nodelay
--
0
PMID: 18267068, 16382138 In addition to p65 phosphorylation, IKK¦Á also may promote Lys310 acetylation through direct phosphorylation of SMRT, which leads to displacement of HDAC3 from the SMRT corepressor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c304 : 1
stoichiometry:c306 : 1
stoichiometry:c305 : 1
m119*m117*0.1
nodelay
--
0
PMID: 18267068, 12789343, 12789342 IKK¦Á is found associated with the ¦ÊB sites of some NF-¦ÊB-responsive genes, and stimulus-induced phosphorylation of histone H3 on serine 10 does not occur in the absence of IKK¦Á
p108
p108
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c292 : 1
stoichiometry:c308 : 1
stoichiometry:c307 : 1
m2282*m117*0.1
nodelay
--
0
PMID: 18267068, 17434128 In addition to the SMRT and N-CoR (nuclear receptor corepressor) complexes, IKK¦Á also has been shown to phosphorylate the CBP coactivator
--
and
mass
coefficient1:0.1
coefficient2:1.0
1.0*0.1
nodelay
--
0
--
p11
p11
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c195 : 1
stoichiometry:c25 : 1
m18*m3459*m110*0.1
nodelay
--
0
PMID: 18267068, 17072324 Phosphorylation of the conserved serine residues (DS*GXXS*) in I¦ÊB proteins results in their K48-linked polyubiquitination by ¦ÂTrCP containing Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF) E3 ubiquitin ligase complexes (SCF¦ÂTrCP) coordinately with the E2 UbcH5.
p110
p110
cso30:i:ME_Dissociation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c310 : 1
stoichiometry:c311 : 1
stoichiometry:c312 : 1
m118*0.1
nodelay
--
0
PMID: 18267068, 16382138 In addition to p65 phosphorylation, IKK¦Á also may promote Lys310 acetylation through direct phosphorylation of SMRT, which leads to displacement of HDAC3 from the SMRT corepressor complex.
PMID: 18267068 Figure.4
p112
p112
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c315 : 1
stoichiometry:c316 : 1
stoichiometry:c317 : 1
stoichiometry:c314 : 1
m2282*m220*0.1
nodelay
--
0
PMID: 18267068, 17434128 It was recently reported that IKK¦Á phosphorylates CBP in a stimulus-dependent manner, inducing upregulation of CBP activity, increased binding to p65, and decreased binding to p53
p113
p113
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c318 : 1
stoichiometry:c320 : 1
stoichiometry:c319 : 1
m2057*m2177*0.1
nodelay
--
0
PMID: 18267068, 16007092 GSK3¦Â, normally constitutively active, phosphorylates and inactivates CREB disrupting the interaction between CREB and CBP
p114
p114
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c321 : 1
stoichiometry:c322 : 1
stoichiometry:c324 : 1
stoichiometry:c323 : 1
m2057*m2282*0.1
nodelay
--
0
PMID: 18267068, 16007092 GSK3¦Â, normally constitutively active, phosphorylates and inactivates CREB disrupting the interaction between CREB and CBP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c325 : 1
stoichiometry:c326 : 1
stoichiometry:c327 : 1
m2057*m121*0.1
nodelay
--
0
PMID: 18267068 One potential explanation is that CBP bound to CREB is a poor substrate for IKK¦Á phosphorylation, and that CBP phosphorylated by IKK¦Á binds poorly to CREB.
p116
p116
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c328 : 1
stoichiometry:c329 : 1
stoichiometry:c330 : 1
m115*m44464*0.1
nodelay
--
0
PMID: 18267068, 18045535 One recent and intriguing addition to this list is ribosomal protein S3 (RPS3), which seems to be required for the binding of NF-¦ÊB at specific ¦ÊB sites
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c331 : 1
stoichiometry:c332 : 1
1.0*0.1
nodelay
--
0
PMID: 18267068, 17377533 IKK¦Á represses transcription of the tumor suppressor Maspin by acting at the maspin promoter strongly supports a direct mechanism of action by IKK¦Á that is independent of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c333 : 1
stoichiometry:c334 : 1
stoichiometry:c335 : 1
stoichiometry:c336 : 1
m128*m129*m115*0.1
nodelay
--
0
PMID: 18267068, 17183367 Although the exact mechanism of action remains unclear, it has recently been shown that targeting the SOCS-1-containing ubiquitin ligase complex (ECSSOCS1) to p65-containing dimers is carried out by COMMD1 (Copper Metabolism MURR1 Domain containing-1) proteins
p119
p119
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c340 : 1
stoichiometry:c338 : 1
stoichiometry:c339 : 1
m115*m117*0.1
nodelay
--
0
PMID: 18267068, 15858576, 16116086 IKK¦Á is also involved in termination of inflammatory transcriptional responses in macrophages, possibly by promoting the nuclear degradation of both p65 and c-Rel
p12
p12
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m15*0.1
nodelay
--
0
PMID: 18267068, 17072324 Phosphorylation of the conserved serine residues (DS*GXXS*) in I¦ÊB proteins results in their K48-linked polyubiquitination by ¦ÂTrCP containing Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF) E3 ubiquitin ligase complexes (SCF¦ÂTrCP) coordinately with the E2 UbcH5.
p120
p120
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c341 : 1
stoichiometry:c343 : 1
stoichiometry:c342 : 1
m165*m117*0.1
nodelay
--
0
PMID: 18267068, 15858576, 16116086 IKK¦Á is also involved in termination of inflammatory transcriptional responses in macrophages, possibly by promoting the nuclear degradation of both p65 and c-Rel
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c344 : 1
stoichiometry:c345 : 1
stoichiometry:c346 : 1
m48*m1637*0.1
nodelay
--
0
PMID: 18267068, 16547522 RIP also becomes rapidly ubiquitinated following TNF¦Á stimulation, and it has been proposed that it is through this posttranslational modification that RIP1 binds to NEMO.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c347 : 1
stoichiometry:c348 : 1
m133*0.1
nodelay
--
0
PMID: 18267068 Conformational changes in the IKK complex induced by binding of NEMO to RIP, and/or ubiquitination of NEMO, lead to the exposure of IKK kinase domain and T loop serines and consequent transautophosphorylation or phosphorylation by an IKK-K such as TAK1.
p123
p123
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c349 : 1
stoichiometry:c352 : 1
stoichiometry:c350 : 1
stoichiometry:c351 : 1
m134*m1573*0.1
nodelay
--
0
PMID: 18267068 Conformational changes in the IKK complex induced by binding of NEMO to RIP, and/or ubiquitination of NEMO, lead to the exposure of IKK kinase domain and T loop serines and consequent transautophosphorylation or phosphorylation by an IKK-K such as TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c353 : 1
stoichiometry:c354 : 1
m135*0.1
nodelay
--
0
PMID: 18267068 The active IKK then phosphorylates downstream substrates, including serine 740 within the IKK NBD and serine 68 in NEMO.
p125
p125
cso30:i:ME_Dissociation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c355 : 1
stoichiometry:c356 : 1
stoichiometry:c357 : 1
stoichiometry:c358 : 1
m136*0.1
nodelay
--
0
PMID: 18267068 NEMO phosphorylation results in the separation of stable NEMO dimers and NEMO binding to IKK.
p126
p126
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c359 : 1
stoichiometry:c360 : 1
stoichiometry:c361 : 1
m137*m1703*0.1
nodelay
--
0
PMID: 18267068, 16126728, 17188031 the protein phosphatase 2A (PP2A) has been shown to associate with IKK and potentiate IKK activation in cells
p127
p127
cso30:i:ME_Dephosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c362 : 1
stoichiometry:c363 : 1
m138*0.1
nodelay
--
0
PMID: 18267068, 16126728, 14585847, 17977820 structural changes induced by NEMO Ser68 and IKK NBD phosphorylation may allow dephosphorylation of the activation loop serines in IKKs as well as N-terminal phosphorylation sites in NEMO by PP2A or PP2C¦Â
p128
p128
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c366 : 1
stoichiometry:c367 : 1
stoichiometry:c364 : 1
stoichiometry:c365 : 1
m183*m6443*m75*0.1
nodelay
--
0
PMID: 18267068, 17947236, 18079694, 17277144 Similar to RIP1, the kinase activity of RIP2 does not appear to be required, and RIP2 is also ubiquitinated through the action of Ubc13/TRAF6
p129
p129
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c368 : 1
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c369 : 1
m76*m1573*m140*0.1
nodelay
--
0
PMID: 18267068, 17562858, 17965022 RIP2 acts with TAK1 and TRAFs to induce NEMO ubiquitination and downstream signaling pathways
p13
p13
cso30:i:ME_Translocation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c33 : 1
stoichiometry:c272 : 1
m19*0.1
nodelay
--
0
PMID: 18267068, 17072323 The released NF-¦ÊB dimers bind promoter and enhancer regions containing ¦ÊB consensus sequences 5¡ì GGGRNWYYCC 3¡ì (N¡½any base; R¡½purine; W¡½adenine or thymine; and Y¡½pyrimidine)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c34 : 1
m22*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c279 : 1
stoichiometry:c38 : 1
m12*m111*0.1
nodelay
--
0
PMID: 18267068, 17072323 The released NF-¦ÊB dimers bind promoter and enhancer regions containing ¦ÊB consensus sequences 5¡ì GGGRNWYYCC 3¡ì (N¡½any base; R¡½purine; W¡½adenine or thymine; and Y¡½pyrimidine)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m185*m24*0.1
nodelay
--
0
PMID: 18267068 Thus when IL-1R binds IL-1 or RIG-I binds cytoplasmic dsRNA they activate overlapping but unique signaling pathways due to these differences in upstream signaling components, and hence they induce distinct transcriptional programs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m23*m1572*0.1
nodelay
--
0
PMID: 18267068, 17047224 For example, IL-1R and RIG-I, which both signal through TRAF6 to IKK, do so through distinct receptor proximal adaptor components MyD88 and MAVS, respectively
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m41844*m119368*0.1
nodelay
--
0
PMID: 18267068 Thus when IL-1R binds IL-1 or RIG-I binds cytoplasmic dsRNA they activate overlapping but unique signaling pathways due to these differences in upstream signaling components, and hence they induce distinct transcriptional programs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m26*m68199*0.1
nodelay
--
0
PMID: 18267068, 17047224 For example, IL-1R and RIG-I, which both signal through TRAF6 to IKK, do so through distinct receptor proximal adaptor components MyD88 and MAVS, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m6*0.1
nodelay
--
0
PMID: 18267068, 11983155 The exposed NLS of p50 coupled with nuclear export sequences (NES) in I¦ÊB¦Á and p65 leads to constant shuttling of I¦ÊB¦Á/NF-¦ÊB complexes between the nucleus and the cytoplasm, despite steady-state localization that appears almost exclusively cytosolic
p20
p20
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c59 : 1
stoichiometry:c58 : 1
m230*m177*0.1
nodelay
--
0
PMID: 18267068, 8565075 Following binding of TNF¦Á, TRAF2 is recruited to TNFR1 through its interaction with TRADD
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c146 : 1
stoichiometry:c52 : 1
m27*m1637*0.1
nodelay
--
0
PMID: 18267068 It is important to bear in mind that although diverse upstream events may mediate IKK activation through a common mechanism, parallel signaling pathways emanating from nonredundant receptor proximal signaling components frequently produce crosstalk that shapes the NF-¦ÊB response in ways that are unique to individual signaling pathways. PMID: 18267068 The core elements of NF-¦ÊB signaling pathways are generally several steps removed from the receptor itself. The intervening steps between receptor and IKK form links to parallel signaling pathways.
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c54 : 1
stoichiometry:c21 : 1
m25*m1637*0.1
nodelay
--
0
PMID: 18267068 It is important to bear in mind that although diverse upstream events may mediate IKK activation through a common mechanism, parallel signaling pathways emanating from nonredundant receptor proximal signaling components frequently produce crosstalk that shapes the NF-¦ÊB response in ways that are unique to individual signaling pathways. PMID: 18267068 The core elements of NF-¦ÊB signaling pathways are generally several steps removed from the receptor itself. The intervening steps between receptor and IKK form links to parallel signaling pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m29*m178*0.1
nodelay
--
0
PMID: 18267068, 8565075 Following binding of TNF¦Á, TRAF2 is recruited to TNFR1 through its interaction with TRADD
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m30*m180*0.1
nodelay
--
0
PMID: 18267068, 8565075 Following binding of TNF¦Á, TRAF2 is recruited to TNFR1 through its interaction with TRADD
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m30*m1874*0.1
nodelay
--
0
PMID: 18267068 TRAF5 was also shown to interact with the TNFR1 signaling complex,
p26
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c70 : 1
stoichiometry:c73 : 1
m32*m1637*0.1
nodelay
--
0
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m31*m1637*0.1
nodelay
--
0
PMID: 18267068 TRAF2 and TRAF5 are together required for NF-¦ÊB activation by TNFR1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c77 : 1
stoichiometry:c76 : 1
m25*m183*0.1
nodelay
--
0
PMID: 18267068, 17047224, 17072327 In Toll/IL-1 signaling TRAF6 is recruited to the receptor complex and is necessary for MyD88-dependent activation of NF-¦ÊB by IL-1 and ligands of TLR4
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 18267068, 17047224, 17072327 In Toll/IL-1 signaling TRAF6 is recruited to the receptor complex and is necessary for MyD88-dependent activation of NF-¦ÊB by IL-1 and ligands of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m11*0.1
nodelay
--
0
PMID: 18267068, 11983155 The exposed NLS of p50 coupled with nuclear export sequences (NES) in I¦ÊB¦Á and p65 leads to constant shuttling of I¦ÊB¦Á/NF-¦ÊB complexes between the nucleus and the cytoplasm, despite steady-state localization that appears almost exclusively cytosolic
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m34*m1572*0.1
nodelay
--
0
PMID: 18267068, 17047224, 17072327 In Toll/IL-1 signaling TRAF6 is recruited to the receptor complex and is necessary for MyD88-dependent activation of NF-¦ÊB by IL-1 and ligands of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m35*m183*0.1
nodelay
--
0
PMID: 18267068, 17047224, 17072327 In Toll/IL-1 signaling TRAF6 is recruited to the receptor complex and is necessary for MyD88-dependent activation of NF-¦ÊB by IL-1 and ligands of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m1872*m37*0.1
nodelay
--
0
PMID: 18267068, 15708970 TRAF3, which interacts with receptors that trigger the alternative pathway, also interacts with NIK and it now appears that theactivation of NIK is negatively regulated by TRAF3.
p33
p33
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c159 : 1
stoichiometry:c158 : 1
m174*m2617*0.1
nodelay
--
0
PMID: 18267068, 17996648, 18022362, 18022363 In addition to TRAF3, cIAP1 and cIAP2 have been implicated as E3 ligases responsible for regulating constitutive NIK levels
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m38*m174*0.1
nodelay
--
0
PMID: 18267068, 15708970 TRAF3, which interacts with receptors that trigger the alternative pathway, also interacts with NIK and it now appears that the activation of NIK is negatively regulated by TRAF3.
p35
p35
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m174*m1872*0.1
nodelay
--
0
PMID: 18267068, 15084608 In the resting state, TRAF3 induces NIK ubiquitination and degradation, but upon stimulation TRAF3 undergoes signal-dependent degradation, mediated by other TRAF family members, resulting in the accumulation and activation of NIK and consequent activation of the noncanonical pathway
p36
p36
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m41*0.1
nodelay
--
0
PMID: 18267068, 15084608 In the resting state, TRAF3 induces NIK ubiquitination and degradation, but upon stimulation TRAF3 undergoes signal-dependent degradation, mediated by other TRAF family members, resulting in the accumulation and activation of NIK and consequent activation of the noncanonical pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m40*0.1
nodelay
--
0
PMID: 18267068, 15084608 In the resting state, TRAF3 induces NIK ubiquitination and degradation, but upon stimulation TRAF3 undergoes signal-dependent degradation, mediated by other TRAF family members, resulting in the accumulation and activation of NIK and consequent activation of the noncanonical pathway
p38
p38
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m42*0.1
nodelay
--
0
PMID: 18267068, 15084608 In the resting state, TRAF3 induces NIK ubiquitination and degradation, but upon stimulation TRAF3 undergoes signal-dependent degradation, mediated by other TRAF family members, resulting in the accumulation and activation of NIK and consequent activation of the noncanonical pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m43*m31*0.1
nodelay
--
0
PMID: 18267068 RIP family members have been implicated in most TRAF-dependent pathways, e.g., signaling from TNFR superfamily and Toll/IL-1R. PMID: 18267068 RIP1 binds to NEMO and is essential for TNF¦Á-induced IKK and NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c235 : 1
stoichiometry:c236 : 1
m166*m16*0.1
nodelay
--
0
PMID: 18267068, 17254973 In addition to I¦ÊB¦Á/¦Â/var epsilon, p100 can also act as a traditional I¦ÊB regulating p65-containing complexes downstream of IKK¦Á
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c116 : 1
stoichiometry:c112 : 1
m43*m1637*0.1
nodelay
--
0
PMID: 18267068, 8565075, 9529147, 8947041, 10755617 RIP1 binds to NEMO and is essential for TNF¦Á-induced IKK and NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m45*0.1
nodelay
--
0
PMID: 18267068, 8565075, 9529147, 8947041, 10755617 RIP1 binds to NEMO and is essential for TNF¦Á-induced IKK and NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c179 : 1
stoichiometry:c117 : 1
m31*m1637*0.1
nodelay
--
0
PMID: 18267068, 11359906 In the absence of RIP1, IKK recruitment occurs through TRAF2 but does not lead to IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m44*0.1
nodelay
--
0
PMID: 18267068, 16603398, 16543241 RIP1 is inducibly ubiquitinated by TRAF2 following TNF¦Á stimulation. PMID: 18267068, 16547522 RIP also becomes rapidly ubiquitinated following TNF¦Á stimulation, and it has been proposed that it is through this posttranslational modification that RIP1 binds to NEMO.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c122 : 1
stoichiometry:c121 : 1
m34*m18998*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m49*m43*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c126 : 1
m119368*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m64*m18998*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m65*m43*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c136 : 1
stoichiometry:c135 : 1
m68*m66*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m168*0.1
nodelay
--
0
PMID: 18267068 Constitutive binding of p50 or p52 homodimers to ¦ÊB sites on NF-¦ÊB-responsive promoters may thus act to check NF-¦ÊB transactivation until displaced by transcriptionally competent NF-¦ÊB dimers.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c139 : 1
stoichiometry:c138 : 1
m68*m63*0.1
nodelay
--
0
PMID: 18267068, 15064760, 16115877 In addition to TNFR1 signaling, and IKK activation via other death domain-containing TNFR family members, RIP1 has also been reported to be required for TRIF-dependent NF-¦ÊB activation via TLR3 and TLR4, as well as for NF-¦ÊB activation via RIG-I
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m1593*0.1
nodelay
--
0
PMID: 18267068, 15107419, 12612076, 17924664 NEMO can form tetramers in vitro and also is reported to oligomerize in vivo, although the stoichiometry of endogenous NEMO is debatable
p52
p52
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m182*m109*0.1
nodelay
--
0
PMID: 18267068 both IKK¦Á and IKK¦Â phosphorylate I¦ÊB¦Á at Ser32 and Ser36 and I¦ÊB¦Â at Ser19 and Ser23 PMID: 18267068, 9721103 I¦ÊB¦Á bound to NF-¦ÊB is thought to be a preferred substrate to free I¦ÊB¦Á PMID: 18267068 both IKK¦Á and IKK¦Â prefer I¦ÊB¦Á to I¦ÊB¦Â, which is consistent with the difference in I¦ÊB¦Á and ¦Â degradation
p53
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c194 : 1
stoichiometry:c55 : 1
m1637*m85*0.1
nodelay
--
0
PMID: 18267068 Both BCL10 and CARD11 (CARMA1) are CARD-containing proteins that are crucial for IKK activation downstream of either the T cell or B cell antigen receptors. PMID: 18267068, 17098202 The most notable feature of the BCL10, CARD11, MALT1 (CBM) complex is its induced oligomerization following signaling, which is thought to be a key event in IKK activation downstream of these CARD-containing adaptor proteins
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m74*m2684*0.1
nodelay
--
0
PMID: 18267068 Members of the NOD-LRR family of intracellular pattern recognition receptors are CARD-containing proteins that can activate IKK¦Â via RIP2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c111 : 1
stoichiometry:c154 : 1
m75*m1637*0.1
nodelay
--
0
PMID: 18267068, 10880512 RIP2 binds to NEMO and is believed to directly mediate activation of the IKK complex by proximity-induced mechanisms
p57
p57
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c90 : 1
stoichiometry:c22 : 1
m39*m174*0.1
nodelay
--
0
PMID: 18267068, 17047224 NIK directly phosphorylates and activates IKK¦Á. PMID: 18267068, 17047224, 17072322 The alternative pathway relies on the activation of IKK¦Á by the NF-¦ÊB-inducing kinase (NIK). PMID: 18267068 Active IKK¦Â is phosphorylated on two serines, Ser177 and Ser181, within the activation loop of the kinase domain, and IKK¦Á is similarly phosphorylated on activation loop serine residues 176 and 180.
p58
p58
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c162 : 1
stoichiometry:c161 : 1
m174*m2618*0.1
nodelay
--
0
PMID: 18267068, 17996648, 18022362, 18022363 In addition to TRAF3, cIAP1 and cIAP2 have been implicated as E3 ligases responsible for regulating constitutive NIK levels
p59
p59
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c165 : 1
stoichiometry:c164 : 1
m39*m182*0.1
nodelay
--
0
PMID: 18267068, 10823818 It appears that IKK¦Á and IKK¦Â preferentially form heterodimers in vivo, and in vitro studies indicate that IKK¦Á/IKK¦Â heterodimers have higher catalytic efficiency than either homodimer
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m1622*m12*0.1
nodelay
--
0
PMID: 18267068 Constitutive binding of p50 or p52 homodimers to ¦ÊB sites on NF-¦ÊB-responsive promoters may thus act to check NF-¦ÊB transactivation until displaced by transcriptionally competent NF-¦ÊB dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
m39*0.1
nodelay
--
0
PMID: 18267068, 9346484, 9346485, 9346241 IKK¦Á and IKK¦Â dimerize through the leucine zipper domain, which is also required for kinase activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m182*0.1
nodelay
--
0
PMID: 18267068, 9346484, 9346485, 9346241 IKK¦Á and IKK¦Â dimerize through the leucine zipper domain, which is also required for kinase activity.
p62
p62
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m182*m1593*0.1
nodelay
--
0
PMID: 18267068, 12244103, 10968790 IKK¦Á and IKK¦Â bind NEMO through the C-terminal hexapeptide NEMO-binding domain (NBD) (Leu-Asp-Trp-Ser-Trp-Leu) PMID: 18267068, 12244103 Competition experiments and biophysical analyses using the NBD peptide indicate that IKK¦Â binds to NEMO with considerably higher affinity than IKK¦Á
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m39*m1593*0.1
nodelay
--
0
PMID: 18267068, 12244103, 10968790 IKK¦Á and IKK¦Â bind NEMO through the C-terminal hexapeptide NEMO-binding domain (NBD) (Leu-Asp-Trp-Ser-Trp-Leu) PMID: 18267068, 12244103 Competition experiments and biophysical analyses using the NBD peptide indicate that IKK¦Â binds to NEMO with considerably higher affinity than IKK¦Á
p64
p64
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c176 : 1
stoichiometry:c177 : 1
m73*m11981*0.1
nodelay
--
0
PMID: 18267068 Multiple lines of evidence point toward an IKK kinase complex that is composed of only IKK¦Á, IKK¦Â, and NEMO. PMID: 18267068, 17924664 Recombinant NEMO and IKK¦Â appear to associate in a 2:2 molar ratio and the minimum interaction domains form a dimer of dimers (tetramer) that can further assemble into octamers and dodecamers
p65
p65
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
stoichiometry:c180 : 1
m1637*m5516*m5515*0.1
nodelay
--
0
PMID: 18267068 The first is the kinase chaperone HSP-90/Cdc37 that has been reported to constitutively associate with the IKK complex.
p66
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c183 : 1
stoichiometry:c184 : 1
stoichiometry:c182 : 1
m1637*m230*0.1
nodelay
--
0
PMID: 18267068, 11864612 The HSP-90 inhibitor geldanamycin has also been shown to inhibit activation of IKK by TNF-¦Á
p67
p67
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m1637*m40137*0.1
nodelay
--
0
PMID: 18267068, 15218148 The second interacting protein that requires mentioning is ELKS, which has been proposed to be a regulatory component of the IKK complex in addition to NEMO
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m182*0.1
nodelay
--
0
PMID: 18267068 Active IKK¦Â is phosphorylated on two serines, Ser177 and Ser181, within the activation loop of the kinase domain, and IKK¦Á is similarly phosphorylated on activation loop serine residues 176 and 180.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c193 : 1
m72*m70*m71*0.1
nodelay
--
0
PMID: 18267068 Both BCL10 and CARD11 (CARMA1) are CARD-containing proteins that are crucial for IKK activation downstream of either the T cell or B cell antigen receptors. PMID: 18267068, 17098202 The most notable feature of the BCL10, CARD11, MALT1 (CBM) complex is its induced oligomerization following signaling, which is thought to be a key event in IKK activation downstream of these CARD-containing adaptor proteins PMID: 18267068, 17098202 In AgR signaling the CBM complex also assembles into a higher-order oligomer following signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m168*m92*0.1
nodelay
--
0
PMID: 18267068, 17072328, 16470223 Because p100 undergoes constitutive processing in certain tissues, RelB/p52 heterodimers may exhibit constitutive activation and RelB-deficient mice have decreased baseline NF-¦ÊB activity in the thymus and spleen
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c145 : 1
stoichiometry:c148 : 1
m39*m109*0.1
nodelay
--
0
PMID: 18267068 both IKK¦Á and IKK¦Â phosphorylate I¦ÊB¦Á at Ser32 and Ser36 and I¦ÊB¦Â at Ser19 and Ser23 PMID: 18267068, 9721103 I¦ÊB¦Á bound to NF-¦ÊB is thought to be a preferred substrate to free I¦ÊB¦Á PMID: 18267068 both IKK¦Á and IKK¦Â prefer I¦ÊB¦Á to I¦ÊB¦Â, which is consistent with the difference in I¦ÊB¦Á and ¦Â degradation
p71
p71
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c198 : 1
stoichiometry:c202 : 1
stoichiometry:c199 : 1
m200*m182*0.1
nodelay
--
0
PMID: 18267068 both IKK¦Á and IKK¦Â phosphorylate I¦ÊB¦Á at Ser32 and Ser36 and I¦ÊB¦Â at Ser19 and Ser23 PMID: 18267068 both IKK¦Á and IKK¦Â prefer I¦ÊB¦Á to I¦ÊB¦Â, which is consistent with the difference in I¦ÊB¦Á and ¦Â degradation
p72
p72
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c203 : 1
stoichiometry:c201 : 1
m200*m39*0.1
nodelay
--
0
PMID: 18267068 both IKK¦Á and IKK¦Â phosphorylate I¦ÊB¦Á at Ser32 and Ser36 and I¦ÊB¦Â at Ser19 and Ser23 PMID: 18267068 both IKK¦Á and IKK¦Â prefer I¦ÊB¦Á to I¦ÊB¦Â, which is consistent with the difference in I¦ÊB¦Á and ¦Â degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c204 : 1
m20*0.1
nodelay
--
0
PMID: 18267068 The nuclear NF-¦ÊB drives I¦ÊB¦Á expression generating a negative feedback loop.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m20*0.1
nodelay
--
0
PMID: 18267068 Like I¦ÊB¦Á, I¦ÊBvar epsilon is degraded in an IKK-dependent manner and its expression is upregulated by NF-¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c210 : 1
m22*m89*0.1
nodelay
--
0
PMID: 18267068, 8816457, 7867065 I¦ÊB¦Â is capable of associating with NF-¦ÊB dimers that are bound to DNA.
p76
p76
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c211 : 1
stoichiometry:c213 : 1
stoichiometry:c212 : 1
m171*m182*0.1
nodelay
--
0
PMID: 18267068, 17072324, 15371334 Multiple reports have demonstrated that IKK¦Â-dependent phosphorylation of the C-terminal region of p105 at Ser923 and Ser927 (Ser933 in human p105) leads to complete degradation of the protein analogous to I¦ÊB¦Á
p77
p77
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c216 : 1
stoichiometry:c217 : 1
stoichiometry:c215 : 1
m55989*m232*0.1
nodelay
--
0
PMID: 18267068, 16619030 Normal processing of p105 to p50 in an E1 Ub-activating enzyme-deficient cell line, complemented by in vitro analysis, strongly suggests that p105 processing can occur via the 20S proteasome, independent of ubiquitination, and in a manner that is inconsistent with cotranslational processing
p78
p78
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c220 : 1
stoichiometry:c219 : 1
m171*m68*0.1
nodelay
--
0
PMID: 18267068 Thus unprocessed p105 acts as an I¦ÊB protein that binds NF-¦ÊB dimers and can be inducibly degraded upon IKK activation.
p79
p79
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c222 : 1
stoichiometry:c223 : 1
m91*0.1
nodelay
--
0
PMID: 18267068 Thus unprocessed p105 acts as an I¦ÊB protein that binds NF-¦ÊB dimers and can be inducibly degraded upon IKK activation.
PMID: 18267068, 16732290 Likewise it has been shown that in T cells p100 also limits p65-mediated NF-¦ÊB activity in a negative feedback loop set up following T cell activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c225 : 1
stoichiometry:c226 : 1
m16*m92*0.1
nodelay
--
0
PMID: 18267068, 11687592 Regulation of RelB by p100 is especially crucial because RelB-containing dimers only associate with p100, and it has been suggested that they require p100 binding for stabilization
p81
p81
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m173*m3459*0.1
nodelay
--
0
PMID: 18267068, 16303288, 12185077, 14676825 Phosphorylation of p100 at serines 866, 870, and 872 (Ser865, 869, and 871 in human p100) leads to the recruitment of SCF¦ÂTrCP, polyubiquitination of Lys855 in a region with sequence homology to Lys22 of I¦ÊB¦Á, and subsequent degradation or processing to p52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m94*0.1
nodelay
--
0
PMID: 18267068, 16303288, 12185077, 14676825 Phosphorylation of p100 at serines 866, 870, and 872 (Ser865, 869, and 871 in human p100) leads to the recruitment of SCF¦ÂTrCP, polyubiquitination of Lys855 in a region with sequence homology to Lys22 of I¦ÊB¦Á, and subsequent degradation or processing to p52
p83
p83
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c232 : 1
stoichiometry:c233 : 1
stoichiometry:c234 : 1
m95*0.1
nodelay
--
0
PMID: 18267068 The noncanonical or alternative NF-¦ÊB pathway, however, proceeds through proteasomal processing, rather than degradation, of p100 to p52, thereby liberating p52 containing NF-¦ÊB dimers that drive a transcriptional response that is distinct from that induced by the canonical, I¦ÊB¦Á-regulated pathway. PMID: 18267068, 16303288, 12185077, 14676825 Phosphorylation of p100 at serines 866, 870, and 872 (Ser865, 869, and 871 in human p100) leads to the recruitment of SCF¦ÂTrCP, polyubiquitination of Lys855 in a region with sequence homology to Lys22 of I¦ÊB¦Á, and subsequent degradation or processing to p52
p84
p84
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c237 : 1
stoichiometry:c238 : 1
stoichiometry:c239 : 1
m204*m1622*0.1
nodelay
--
0
PMID: 18267068 Bcl-3 is found in the nucleus associated with p50- and p52-containing homo- and heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c241 : 1
stoichiometry:c242 : 1
m20*m204*0.1
nodelay
--
0
PMID: 18267068 Bcl-3 is found in the nucleus associated with p50- and p52-containing homo- and heterodimers.
p86
p86
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c244 : 1
stoichiometry:c245 : 1
m1621*m204*0.1
nodelay
--
0
PMID: 18267068 Bcl-3 is found in the nucleus associated with p50- and p52-containing homo- and heterodimers. PMID: 18267068, 17673665 Bcl-3 may also stabilize repressive p50 homodimers and inhibit NF-¦ÊB activation by preventing the access of TAD-containing dimers to ¦ÊB sites
p87
p87
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c247 : 1
m204*0.1
nodelay
--
0
PMID: 18267068, 12808109, 11713278 Cyclin D1 is a Bcl-3-regulated gene that is of particular interest owing to its role in cell proliferation and cancer.
p88
p88
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c248 : 1
m204*0.1
nodelay
--
0
PMID: 18267068, 16384933 Bcl-3 has also recently been implicated in the regulation of p53 by enhancing the transcription of Hdm2 in normal and cancer cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c252 : 1
stoichiometry:c251 : 1
m23*0.1
nodelay
--
0
PMID: 18267068, 15371334 I¦ÊB¦Æ is not expressed constitutively but rather is upregulated in response to IL-1 and TLR4 ligands, but not TNF, and upon expression localizes to the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c271 : 1
stoichiometry:c2 : 1
m81*m109*0.1
nodelay
--
0
PMID: 18267068 Degradation of I¦ÊB is a rapidly induced signaling event that is initiated upon specific phosphorylation of these molecules by activated IKK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c250 : 1
m34*0.1
nodelay
--
0
PMID: 18267068, 15371334 I¦ÊB¦Æ is not expressed constitutively but rather is upregulated in response to IL-1 and TLR4 ligands, but not TNF, and upon expression localizes to the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c258 : 1
stoichiometry:c254 : 1
m102*m23*0.1
nodelay
--
0
PMID: 18267068, 15371334 I¦ÊB¦Æ is not expressed constitutively but rather is upregulated in response to IL-1 and TLR4 ligands, but not TNF, and upon expression localizes to the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c259 : 1
stoichiometry:c256 : 1
m102*m34*0.1
nodelay
--
0
PMID: 18267068, 15371334 I¦ÊB¦Æ is not expressed constitutively but rather is upregulated in response to IL-1 and TLR4 ligands, but not TNF, and upon expression localizes to the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c261 : 1
m103*0.1
nodelay
--
0
PMID: 18267068, 15371334 I¦ÊB¦Æ is not expressed constitutively but rather is upregulated in response to IL-1 and TLR4 ligands, but not TNF, and upon expression localizes to the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c262 : 1
stoichiometry:c263 : 1
stoichiometry:c264 : 1
m104*m1621*0.1
nodelay
--
0
PMID: 18267068 I¦ÊB¦Æ is inducibly expressed following NF-¦ÊB activation and once expressed associates primarily with p50 homodimers.
p95
p95
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c265 : 1
stoichiometry:c267 : 1
stoichiometry:c268 : 1
stoichiometry:c266 : 1
m106*m1621*m104*0.1
nodelay
--
0
PMID: 18267068, 15241416 I¦ÊB¦Æ is found associated with p50 on the promoter of IL-6, which is not inducibly expressed in I¦ÊB¦Æ knockout cells, and it is, therefore, hypothesized that I¦ÊB¦Æ acts as a coactivator for p50 homodimers
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m17*0.1
nodelay
--
0
PMID: 18267068, 9660950 PKA exists in a complex with cytosolic NF-¦ÊB:I¦ÊB complexes and following degradation of I¦ÊB¦Á phosphorylates p65 at Ser276, promoting the interaction of p65 with the transcriptional coactivators CBP (CREB-binding protein) and p300
p97
p97
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c273 : 1
stoichiometry:c275 : 1
stoichiometry:c274 : 1
m20*m3621*0.1
nodelay
--
0
PMID: 18267068 In addition to PKA, other kinases, most notably MSK1 and MSK2 (mitogen- and stress-activated protein kinase), have been reported to phosphorylate Ser276 of p65.
p98
p98
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c276 : 1
stoichiometry:c278 : 1
stoichiometry:c277 : 1
m20*m112*0.1
nodelay
--
0
PMID: 18267068 In addition to PKA, other kinases, most notably MSK1 and MSK2 (mitogen- and stress-activated protein kinase), have been reported to phosphorylate Ser276 of p65.
p99
p99
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c280 : 1
stoichiometry:c281 : 1
m17*m19*m182*0.1
nodelay
--
0
PMID: 18267068, 15122352, 17072324 IKK¦Á and IKK¦Â have been implicated in the direct phosphorylation of p65 at Ser536
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--